Penumbra

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.

About PEN

Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system. 

CEO
Adam Elsesser
CEOAdam Elsesser
Employees
4,500
Employees4,500
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
2004
Founded2004
Employees
4,500
Employees4,500

PEN Key Statistics

Market cap
11.42B
Market cap11.42B
Price-Earnings ratio
66.86
Price-Earnings ratio66.86
Dividend yield
Dividend yield
Average volume
463.98K
Average volume463.98K
High today
$293.18
High today$293.18
Low today
$280.71
Low today$280.71
Open price
$281.95
Open price$281.95
Volume
249.49K
Volume249.49K
52 Week high
$310.00
52 Week high$310.00
52 Week low
$221.26
52 Week low$221.26

Stock Snapshot

With a market cap of 11.42B, Penumbra(PEN) trades at $291.61. The stock has a price-to-earnings ratio of 66.86.

On 2025-11-21, Penumbra(PEN) stock moved within a range of $280.71 to $293.18. With shares now at $291.61, the stock is trading +3.9% above its intraday low and -0.5% below the session's peak.

Trading activity shows a volume of 249.49K, compared to an average daily volume of 463.98K.

The stock's 52-week range extends from a low of $221.26 to a high of $310.00.

The stock's 52-week range extends from a low of $221.26 to a high of $310.00.

PEN News

TipRanks 6h
Penumbra’s Promising Growth: Buy Rating Backed by Strong Portfolio and Technological Advancements

Penumbra, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Travis Steed from Bank of America Securities maintained a Buy rat...

Simply Wall St 6d
Penumbra: Assessing Valuation After Recent Share Price Gains

Penumbra (PEN) has caught investors’ attention lately, with shares up about 11% over the past month and 18% for the past year. The company’s consistent gains re...

Penumbra: Assessing Valuation After Recent Share Price Gains

Analyst ratings

80%

of 20 ratings
Buy
80%
Hold
15%
Sell
5%

People also own

Based on the portfolios of people who own PEN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.